The biopharma R&D pipeline is unforgiving, and OPKO Health is recruiting a Principal Investigator to anchor their computational biology division. This is a high-stakes, fully remote healthcare and scientific deployment. You aren’t just running scripts in a vacuum; you are translating massive, highly regulated genomic datasets into viable therapeutic targets. Your in silico models will directly dictate where the company invests millions in wet-lab validation and clinical trials, carrying the immense regulatory weight of FDA IND/NDA submissions.
The Biopharma Computational Bottleneck
The modern biopharma sector is currently facing a massive computational bottleneck. While wet-labs generate petabytes of multi-omics data, companies often lack the dry-lab infrastructure to translate it into viable therapeutics. OPKO Health is aggressively closing this gap. They are funding a cloud-based R&D architecture, giving computational biologists the enterprise HPC clusters needed to drive oncology breakthroughs without the usual academic red tape or budget begging.
Clinical Liability & The Dry-Lab Reality
Operating as a dry-lab Principal Investigator requires immense scientific diplomacy and rigorous data governance. You sit at the critical friction point between bioinformatics and physical clinical execution. Wet-lab scientists are inherently skeptical of computational predictions. Your primary objective is to build unassailable, reproducible cloud architectures that process multi-omics data without violating strict clinical compliance or HIPAA protocols. You must mathematically defend your algorithms and convince the broader R&D apparatus that your therapeutic targets justify the severe financial risk of preclinical investment.
Computational Execution & Regulatory Defense
- Computational Triage: Architect and defend highly scalable, cloud-based data pipelines. You must process massive NGS and transcriptomic datasets while strictly managing enterprise compute costs and clinical data privacy.
- Wet-Lab Diplomacy: Force alignment between your decentralized bioinformatics team and the on-site clinical trial directors. You must actively validate your in silico mechanisms of action to skeptical wet-lab researchers.
- Regulatory Authorship: Draft and defend the computational methodologies for FDA regulatory submissions (IND/NDA). If your algorithms lack absolute reproducibility, the regulatory body will reject the pipeline.
- Remote Lab Leadership: Manage a distributed team of data scientists, enforcing uncompromising analytical standards to prevent flawed genomic models from triggering doomed preclinical trials.
Scientific Pedigree & Pipeline Prerequisites
- The Academic Gatekeeper: A Ph.D. in Computational Biology or Genetics is an absolute requirement to possess the scientific authority necessary to direct a biopharma R&D program.
- Biopharma Scar Tissue: 5 to 7 years of post-doctoral or industry survival. You must have a documented track record of pushing multi-omics targets out of the simulation and into actual drug discovery pipelines.
- Cloud & Code Fluency: Expert-level Python and R are the baseline. You must be deeply operational within AWS or GCP, understanding how to deploy heavy distributed compute clusters without bottlenecking the research network.
Compensation & Geographic Arbitrage
This role offers a masterclass in geographic leverage, decoupling tier-one biopharma compensation from the high cost of living in major biotech hubs.
- Base Compensation: $145,000 – $180,000 USD / Year. A strong biopharma baseline, but the true financial strategy lies in the 100% remote capability. You can anchor this Miami-pegged salary in a low-cost geography to optimize your cost of living without sacrificing enterprise pay scales.
- The Equity Structure: Access to Restricted Stock Units (RSUs) means your total compensation ceiling is directly tied to the clinical success of the therapeutic targets your algorithms identify.
- Enterprise Compute Access: OPKO provides the unrestricted high-performance computing (HPC) budgets required to run massive genomic models, removing the bottleneck of underfunded academic servers.
- Corporate Safety Net: Premium medical coverage, 401(k) matching, and structured PTO to mitigate the inevitable burnout of managing high-stakes FDA deadlines.
Deployment Logistics & Remote Architecture
- The Remote Dry-Lab Framework
- Location: 100% Remote (US-Based). You avoid the physical friction of the wet lab, but you are strictly tethered to Eastern Standard Time (EST). You must be online and available to coordinate with the Miami headquarters and clinical teams during core operating hours.
- Relocation Posture
- Not applicable. Maintain your current residency and plug directly into the enterprise R&D cloud architecture from your home office.
Green Flags
- Advantage: Unrestricted Compute Power: You will not be fighting for server time. OPKO provides the enterprise HPC clusters and proprietary datasets necessary to actually execute massive genomic models at scale.
- Advantage: Geographic Arbitrage: This is a tier-one biopharma salary with a 100% remote structure. You can anchor this base salary in a low-cost-of-living geography, effectively optimizing your net earnings.
- Advantage: Autonomy Over Red Tape: You are being brought in to lead the computational biology division, giving you the operational authority to drive clinical breakthroughs without the bureaucratic friction typical of legacy pharmaceutical environments.
Red Flags
- Warning Sign: High-Friction Wet-Lab Diplomacy: Traditional clinical researchers are often highly skeptical of computational models. You will face daily friction convincing the on-site wet-lab teams to bet millions of dollars on your algorithmic predictions.
- Warning Sign: Regulatory Liability: Your code is directly tied to FDA IND/NDA submissions. If your data pipelines are not absolutely flawless and reproducible, the entire therapeutic pipeline stalls. The pressure for mathematical perfection is immense.
